Association between plasma viscosity and all-cause mortality: Results from the MONICA-Augsburg Cohort study 1984-92

British Journal of Haematology

Volumn 109, Issue 2, 2000, Pages 453-458

  Koenig, Wolfgang ^a   Sund, M ^b   Lowel H ^c   Doring A ^c   Ernst, E ^d  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Institute of Epidemiology   (Germany)

^d UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

All cause mortality; Inflammatory response; Plasma viscosity; Prospective observational study

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; HUMAN; MALE; MORTALITY; PLASMA VISCOSITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ACUTE-PHASE REACTION; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CONFIDENCE INTERVALS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK;

EID: 0034121843     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02026.x     Document Type: Article

References (42)

1. Benderly, M., Graff, E., Reicher-Reiss, H., Behar, S., Brunner, D. & Goldbourt, U. (1996) Fibrinogen is a predictor of mortality in coronary heart disease patients. Arteriosclerosis. Thrombosis and Vascular Biology, 16, 351-356.
2. Bray, G.A. (1978) Definition, measurement and classification of the syndromes of obesity. International Journal of Obesity, 2, 99-112.
3. Chambless, L., Cairns, V., Herbold, M., Döring, A., Filipiak, B., Schneller, H., Viessman, M. & Keil, U. (1987) MONICA-Augsburg: survey sampling. GSF-Bericht 31/86. Gesellschaft für Strahlenund Umweltforschung. München.
4. Danesh, J., Collins, R., Appleby, P. & Peto, R. (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Journal of the American Medical Association, 279, 1477-1482.
5. DeLabry, L.O., Campion, E.W., Glynn, R.J. & Vokonas, P.S. (1990) White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. Journal of Clinical Epidemiology, 43, 153-157.
6. Ernst, E., Hammerschmidt, D.E., Bagge, U., Matrai, A. & Dormandy, J.A. (1987) Leukocytes and the risk of ischemic diseases. Journal of the American Medical Association, 257, 2318-2324.
7. Ernst. E., Matrai, A., Saradeth, T., Resch, K.L. & Koenig, W. (1990) The measurement of plasma and blood viscosity. Tijdschrift Nederlandse Veremiging voor Klinische Chemie, 15, 84-88.
8. Folsom, A.R., Wu, K.K., Rosamond, W.D., Sharrett, A.R. & Chambless, L.E. (1997) Prospective study of hemostatic factors and incidence of coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 96, 1102-1108.
9. Gaziano, J.M., Buring, J.E., Breslow, J.L., Goldhaber, S.Z., Rosner, B., Vandenburgh, M., Willett, W.C. & Hennekens, C.H. (1993) Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. New England Journal of Medicine, 329, 1829-1834.
10. Greenland, S. (1989) Modeling and variable selection in epidemiologic analysis. American Journal of Public Health, 79, 340-349.
11. Grimm, R.H., Neaton, J.D. & Ludwig, W. (1985) Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. Journal of the American Medical Association, 254, 1932-1937.
12. Harkness, J. (1963) A new method for the measurement of plasma viscosity. Lancet, ii, 280-281.
13. Heinrich, P.C., Castell, J.V. & Andus, T. (1990) Interleukin-6 and the acute phase response. Biochemical Journal, 265, 621-636.
14. International Committee for Standardization in Haematology. (1984) Recommendation for a selected method for the measurement of plasma viscosity. Journal of Clinical Pathology, 37, 1147-1152.
15. Keil, U., Cairns, V., Döring, A., Härtel. U., Joreik, J., Perz, S. & Stieber, J. (1985) MONICA-Projekt Region Augsburg. Manual of Operations, Survey. GSF-Bericht 20/85. Gesellschaft für Strahlen-und Umweltforschung. München.
16. Keil, U., Stieber, J., Döring, A., Chambless, L., Härtel, U., Filipiak, B., Hense, H.W., Tietze, M. & Gostomzyk, J.G. (1988) The cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/1985. Acta Medica Scandinavica, 728, 119-128.
17. Koenig, W., Sund, M., Döring, A. & Ernst, E. (1997) Leisure-time physical activity but not work-related physical activity is associated with decreased plasma viscosity. Circulation, 95, 335-341.
18. Koenig, W., Sund, M., Filipiak, B., Döring, A., Löwel, H. & Ernst, E. (1998) Plasma viscosity and the risk of coronary heart disease. Results from the MONICA-Augsburg Cohort Follow-up Study 1984/85-1992. Arteriosclerosis. Thrombosis and Vascular Biology, 18, 768-772.
19. Kuller, L.H., Eichner, J.E., Orchard, T.J., Grandits, G.A., McCallum, L. & Tracy, R.P. (1991) The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. American Journal of Epidemiology, 134, 1266-1277.
20. Lowe, G.D.O., Lee, A.J., Rumley, A., Price, J.F. & Fowkes, F.G.R. (1997) Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. British Journal of Haematology, 96, 168-173.
21. MathSoft Inc. (1997) S-PLUS user's Guide, Version 4.0. Mathsoft, Seattle, USA.
22. Munro, J.M. & Cotran, R.S. (1988) The pathogenesis of atherosclerosis: atherogenesis and inflammation. Laboratory Investigation, 58, 249-261.
23. Nieminen, M.S., Mattila, K. & Valtonen, V. (1993) Infection and inflammation as risk factors for myocardial infarction. European Heart Journal, 14, 12-16.
24. Phillips, A., Shaper, A.G. & Whineup, P.H. (1989) Association between serum albumin and mortality from cardiovascular disease, cancer and other cause, Lancet, ii, 1434-1436.
25. Resch, K.L., Ernst, E., Matrai, A. & Paulsen, H.F. (1992) Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Annals of Internal Medicine, 117, 371-375.
26. Rosengren, A. & Wilhelmsen, L. (1996) Fibrinogen, coronary heart disease and mortality from all causes in smokers and non-smokers. The Study of Men Born in 1933. Journal of Internal Medicine, 239, 499-507.
27. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809.
28. Ross, R. (1999) Atherosclerosis - an inflammatory disease. New England Journal of Medicine, 340, 115-126.
29. Rumley, A., Lowe, G.D.O., Norrie. J., Ford. I., Shepherd, J. & Cobbe, S.M. (1997) Blood rheology and outcome in the West of Scotland Coronary Prevention Study: is the benefit of lipoprotein reduction partly due to lower viscosity (Abstract)? British Journal of Haematology, 97, 78.
30. SAS Institute Inc. (1996) SAS/STAT Software. Changes and Enhancements for Release 6.12. SAS Institute Inc., Cary. NC.
31. Soeters, P.B., von Meyenfeld, M.F., Meijering, W.J.H.J., Fredrix, E.W.H.M., Wouters, E.F.M. & Schols, A.M.W.J. (1990) Serum albumin and mortality (Letter). Lancet, 335, 348.
32. Stuart, J., George, A.J., Davies, A.J., Aukland, A. & Hurlow, R.A. (1981) Haematological stress syndrome in atherosclerosis. Journal of Clinical Pathology, 34, 464-467.
33. Sweetnam, P.M., Thomas, H.F., Yarnell, J.W.G., Beswick, A.D., Baker, I.A. & Elwood, P.C. (1996) Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. European Heart Journal, 17, 1814-1820.
34. The Expert Panel. (1988) Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Archives of Internal Medicine, 148, 36-69.
35. Weijenberg, M.P., Feskens, E.J.M. & Kromhout, D. (1996) White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arteriosclerosis. Thrombosis and Vascular Biology, 16, 499-503.
36. WHO MONICA Project. (1989) WHO MONICA Project: objectives and design. International Journal of Epidemiology, 18, 29-37.
37. WHO MONICA Project Principal Investigators. (1988) The World Health Organization Monica Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. Journal of Clinical Epidemiology, 41, 105-114.
38. Wick, G., Roman, M., Amberger, A., Metzler, B., Mayr, M., Falkensammer, G. & Xu, Q. (1997) Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. Federation of American Societies for Experimental Biology Journal, 11, 1199-1207.
39. Woodward, M., Lowe, G.D.O., Rumley, A. & Tunstall-Pedoe, H. (1998) Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study. European Heart Journal, 19, 55-62.
40. World Health Organization. (1990) WHO MONICA project. MONICA Manual. CVD/MNC. WHO, Geneva.
41. Yano, K., Grove, J.S., Chen, R., Rodriguez, B.L., Curb. J.D. & Burns, J.A. (1998) Plasma fibrinogen as a predictor of mortality among elderly Japanese American men: the Honolulu Heart Program. Circulation, 98: 1206-207.
42. Yokoyama, A., Kohno, N., Fujino, S., Hamada, H., Inoue, Y., Fujioka, S., Ishida, S. & Hiwada, K. (1995) Circulating interleukin-6 levels in patients with bronchial asthma. American Journal of Respiratory and Critical Care Medicine, 151, 1354-1358.